Bookhound

Primary

Books

Journals

Old Books

Theses

Catalogs

Bazaars

Fileservers

Online Services

Bookstores

FullText

⏬ ČDK⏬ Archive❌ Crossref❌ LibGen❌ CLEAR ALL

LibGen

AuthorTitlePublishedmd5

CROSSREF (MAX 100)

AuthorTitlePrint-PublishedTypeDOI@Sci-hub
CDKreference-entry10.1007/springerreference_92996
Functions of CDK/cyclin Complexes in Endoreplication Regulation by the CDK Inhibitor SIAMESEdissertation10.31390/gradschool_dissertations.5173
CDKreference-entry10.1007/springerreference_37256
Pandit, J.Novel CDK-5 inhibitors - crystal structure of inhibitor EFQ with CDK-22009/9/8dataset10.2210/pdb3igg/pdb
Pandit, J.Novel CDK-5 inhibitors - crystal structure of inhibitor EFP with CDK-22009/9/8dataset10.2210/pdb3ig7/pdb
Figure 4—figure supplement 1. CDK–phosphorylation of ORC intrinsically inhibits helicase loading.component10.7554/elife.33309.013
CDK Inhibitor R547reference-entry10.32388/iap5sl
Willighagen, Egon10000 CDK commits!posted-content10.59350/w1hpp-ks316
Willighagen, EgonCDK Literature #3posted-content10.59350/rkkty-a3w29
Willighagen, EgonCDK Newsposted-content10.59350/xf9bq-44218
Cermin Dunia Kedokteranjournal10.55175/cdk
Willighagen, EgonCDK Literature #4posted-content10.59350/es4e7-esh15
CDKbook-chapter10.1007/3-540-30683-8_274
CDK Inhibitor AT7519reference-entry10.32388/286jz0
CDK Gene Mutationreference-entry10.32388/kf9klo
Willighagen, EgonCDK Literature #1posted-content10.59350/g22fv-gtc07
Willighagen, EgonStatCVS on CDKposted-content10.59350/q7ehm-v1m81
Hu, X.Cdc2: a monopotent or pluripotent CDK?2011/6journal-article10.1111/j.1365-2184.2011.00753.x
CDKbook-chapter10.1007/978-3-540-47648-1_959
Willighagen, EgonCDK Literature #2posted-content10.59350/17nhx-htt54
Supplementary file 1. CDK sequences used for phylogenetic analysiscomponent10.7554/elife.10767.021
Huang, LindaFaculty Opinions recommendation of Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates.2007/4/23dataset10.3410/f.1080804.533727
Willighagen, EgonNightly CDK builds now availableposted-content10.59350/s63wt-hbx56
Apodaca, Richard L.Updating Ruby CDKposted-content10.59350/yy9a2-wy148
CDK Inhibitor SNS-032reference-entry10.32388/2sggcz
Willighagen, EgonThe CDK data model #1posted-content10.59350/4xfms-7nn46
Willighagen, EgonCDK-Taverna fully recognizedposted-content10.59350/pk40z-7z702
cdkbook-chapter10.1007/3-540-29832-0_321
CDKbook-chapter10.1007/978-3-540-38918-7_5357
Willighagen, EgonCDK Module dependencies #2posted-content10.59350/e7qrk-ypg78
cdkbook-chapter10.1007/3-540-29719-0_321
Willighagen, EgonCDK Workshop - Day #2posted-content10.59350/f7vn0-kqz26
Schreiner, S.Kongenitale Kniegelenkluxation (CDK)2012/1journal-article10.1007/s00132-011-1874-7
Carnero, A.The INK4 Family of CDK Inhibitors1998book-chapter10.1007/978-3-642-71941-7_3
CDK Inhibitorsbook-chapter10.1007/978-3-540-47648-1_963
Valk, ErvinCDK signaling via nonconventional CDK phosphorylation sites2023/11/1journal-article10.1091/mbc.e22-06-0196
journal-issue10.55175/cdk.v48i6
Grigoroudis, Asterios I.Preparation of CDK/Cyclin Inhibitor Complexes for Structural Determination2016book-chapter10.1007/978-1-4939-2926-9_4
Hu, ShanhuTargeting anaphase catastrophe through CDK inhibition in lung cancerdissertation10.1349/ddlp.1623
Degradation by Design: New Cyclin K Degraders from Old CDK Inhibitorscomponent10.1021/acschembio.3c00616.s002
journal-issue10.55175/cdk.v47i7
Willighagen, EgonAtom typing in the CDKposted-content10.59350/wm7aq-eqz10
Apodaca, Richard L.Ruby CDK for Newbiesposted-content10.59350/50ebs-4zq55
Willighagen, EgonCalculating geometrical properties with the CDKposted-content10.59350/sy6r5-pzw09
Willighagen, EgonSingle PDFs for CDK News articlesposted-content10.59350/rgdzb-bfe36
Alvira, DanielDrug Delivery Strategies of Chemical CDK Inhibitors2016book-chapter10.1007/978-1-4939-2926-9_12
Willighagen, EgonJava Server Pages with CDK functionalityposted-content10.59350/3kvks-pdb73
CDK Inhibitory Proteinbook-chapter10.1007/3-540-30683-8_276
Apodaca, Richard L.CDK, the Ruby Wayposted-content10.59350/49w1p-2y164
Willighagen, EgonJumbo 5.0 and the CDKposted-content10.59350/y0mte-4ns18
Willighagen, EgonCDK close to entering Debianposted-content10.59350/dmspa-wyb25
CDK Inhibitors2011book-chapter10.1007/978-3-642-16483-5_963
CDK2011book-chapter10.1007/978-3-642-16483-5_959
journal-issue10.55175/cdk.v48i2
journal-issue10.55175/cdk.v47i11
CDK/JAK2/FLT3 Inhibitor TG02 Citratereference-entry10.32388/xklmgh
Gortat, AnnaAnalysis of CDK Inhibitor Action on Mitochondria-Mediated Apoptosis2016book-chapter10.1007/978-1-4939-2926-9_9
Willighagen, EgonThe CDK data classes and change notificationsposted-content10.59350/3xsm0-bt478
Willighagen, EgonCDK Bug Squash Party - Day 5posted-content10.59350/paxbm-rac78
Willighagen, EgonCDK Workshop - Days #3 and #4posted-content10.59350/kvq10-snm07
CDK-Activating Kinase Assembly Factor MAT1reference-entry10.32388/6s4tbs
journal-issue10.55175/cdk.v49i0
Apodaca, Richard L.Scripting CDK with JRubyposted-content10.59350/sxxfq-shj88
CDK2016book-chapter10.1007/978-3-662-46875-3_100468
Willighagen, EgonCDK Bug Squash Party - Day 2posted-content10.59350/wzs4m-9ky43
Willighagen, EgonThe CDK/Metabolomics/Chemometrics Unconference resultsposted-content10.59350/f2ajz-tmr63
Willighagen, EgonCDK and the Java 6 betaposted-content10.59350/6az21-1dt76
Willighagen, EgonJumbo 5.0 and CML support in CDKposted-content10.59350/dzvnw-3b413
journal-issue10.55175/cdk.v47i10
Willighagen, EgonCDK Bug Squash Party - Day 1posted-content10.59350/y5srm-hzx87
journal-issue10.55175/cdk.v48i4
Hirai, HiroshiEvaluating Chemical CDK Inhibitors as Cell Death Inducers2016book-chapter10.1007/978-1-4939-2926-9_14
Apodaca, Richard L.Porting MX - CDK-Compatible VF Implementationposted-content10.59350/xat1r-hcs92
Willighagen, EgonUML diagram of CDK module dependenciesposted-content10.59350/a3r1n-72841
Apodaca, Richard L.Scripting Molecular Fingerprints with Ruby CDKposted-content10.59350/xgf37-ggz21
Upton, Jason W.Evidence for CDK-Dependent and CDK-Independent Functions of the Murine Gammaherpesvirus 68 v-Cyclin2006/12/15journal-article10.1128/jvi.01722-06
journal-issue10.55175/cdk.v47i8
Lacy, SusanIdentification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes1997/5/22journal-article10.1038/sj.onc.1201085
journal-issue10.55175/cdk.v47i12
grant10.55776/tai3266225
journal-issue10.55175/cdk.v47i9
journal-issue10.55175/cdk.v48i5
Degradation by Design: New Cyclin K Degraders from Old CDK Inhibitorscomponent10.1021/acschembio.3c00616.s001
Schneider, BrandtRole of the Cdk Inhibitor Sic 1 in Start1999/8/1report10.21236/ada378108
Design, Synthesis, and Biological Evaluation for First GPX4 and CDK Dual Inhibitorscomponent10.1021/acs.jmedchem.3c01890.s002
Guevara, TatianaEvaluating the Effects of CDK Inhibitors in Ischemia–Reperfusion Injury Models2016book-chapter10.1007/978-1-4939-2926-9_10
Ruiz, E. JosuéMeiotic Inactivation of Xenopus Myt1 by CDK/XRINGO, but Not CDK/Cyclin, via Site-Specific Phosphorylation2008/10journal-article10.1016/j.molcel.2008.08.029
journal-issue10.55175/cdk.v42i10
journal-issue10.55175/cdk.v48i1
journal-issue10.55175/cdk.v48i3
Design, Synthesis, and Biological Evaluation for First GPX4 and CDK Dual Inhibitorscomponent10.1021/acs.jmedchem.3c01890.s003
Schneider, BrandtRole of the Cdk Inhibitor Sic 1 in Start2000/9/1report10.21236/ada392485
Apodaca, Richard L.CDK, the Ruby Way: RCDK-0.2.0posted-content10.59350/ev966-zz940
Lee, Young-SamRegulation of a Cyclin-CDK-CDK Inhibitor Complex by Inositol Pyrophosphates2007/4/6journal-article10.1126/science.1139080
Guha, Rajarshircdk: Interface to the 'CDK' Libraries2006/10/4dataset10.32614/cran.package.rcdk
Design, Synthesis, and Biological Evaluation for First GPX4 and CDK Dual Inhibitorscomponent10.1021/acs.jmedchem.3c01890.s001
GROTH, AHigh-density growth arrest in Ras-transformed cells: low Cdk kinase activities in spite of absence of p27 Cdk-complexes2005/9journal-article10.1016/j.cellsig.2004.11.021
Gallastegui, EdurneImmunoprecipitation of Cdk–Cyclin Complexes for Determination of Kinase Activity2016book-chapter10.1007/978-1-4939-2926-9_1
Design, Synthesis, and Biological Evaluation for First GPX4 and CDK Dual Inhibitorscomponent10.1021/acs.jmedchem.3c01890.s004
Cyclin-dependent Kinase (CDK) Inhibitorbook-chapter10.1007/3-540-30683-8_390
Apodaca, Richard L.Drawing 2-D Structures with Structure-CDKposted-content10.59350/qxc8d-c1w35
Fisher, Robert PFaculty Opinions recommendation of Meiotic inactivation of Xenopus Myt1 by CDK/XRINGO, but not CDK/cyclin, via site-specific phosphorylation.2008/11/11dataset10.3410/f.1125916.583024
Schneider, BrandtRole of the Cdk Inhibitor Sic 1 in Start1998/8/1report10.21236/ada359281
Gangopadhyay, AditiThe Prospects of CDK Targeting and Clinical Application of CDK Inhibitors in Cancer2018/12/5book-chapter10.2174/9781681087016118090008
Willighagen, EgonCDK 1.0: a milestone after 7 year of developmentposted-content10.59350/qd21w-71g30
Willighagen, EgonThe molecular QSAR descriptors in the CDKposted-content10.59350/47rre-wwc20
lavarone, AntonioRepression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p151997/5journal-article10.1038/387417a0
Chiarelli, CCyclin D, CDK and CDK Inhibitors in Melanocytic Neoplasms.1997/8journal-article10.1097/00000372-199708000-00072
Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk)component10.1021/acschembio.7b00972.s002
Willighagen, EgonTest results for the CDK 1.0.x branchposted-content10.59350/ry980-qya21
Pérez-Benavente, BeatrizCell Synchronization Techniques to Study the Action of CDK Inhibitors2016book-chapter10.1007/978-1-4939-2926-9_8
-, -Indeks Subjekjournal-article10.55175/cdk.v49i2.1746
Willighagen, EgonInChI's in LaTex and CDK Newsposted-content10.59350/hysd0-wvc09
Willighagen, EgonCDK News 2.3 and InChI'sposted-content10.59350/z97vw-87009
Synthesis of benzofuropyridine derivatives as CDK-5 inhibitors and anticancer agentsdissertation10.58837/chula.the.2022.1218
CDKother10.1002/0471684228.egp01945
Guha, Rajarshircdklibs: The CDK Libraries Packaged for R2009/1/8dataset10.32614/cran.package.rcdklibs
-, -Indeks Penulisjournal-article10.55175/cdk.v48i12.1586
Willighagen, EgonCDK Debug classes and fixing the ModelBuilder3D bugposted-content10.59350/6p49t-sj396
Multiplexed Profiling of CDK Kinase Activities in Tumor Biopsies with Fluorescent Peptide Biosensorscomponent10.1021/acssensors.4c00139.s001
Willighagen, EgonCDK Bug Squash Party - Day 3 and 4posted-content10.59350/zwkym-aty79
Figure 3: The efficiency of tumor markers in distinguish CDK patients from healthy control.component10.7717/peerj.19240/fig-3
Willighagen, EgonR/CDK install fails on GCC 4.0 systemsposted-content10.59350/b1vyj-0kd63
grant10.55776/t393
Palomino-Schätzlein, MartinaMetabolomic Applications to the Characterization of the Mode-of-Action of CDK Inhibitors2016book-chapter10.1007/978-1-4939-2926-9_16
-, -Indeks Subjekjournal-article10.55175/cdk.v48i12.1589
Futcher, A. B.General Methods for Identifying G1-phase Substrates of Cdk Protein Kinases1999/6/1report10.21236/ada374137
CDK2008book-chapter10.1007/978-1-4020-6754-9_2580
Many Hats for Cdk Inhibitor2006/1/10journal-article10.1126/stke.3172006tw468
grant10.35802/065956
-, -Indeks Penulisjournal-article10.55175/cdk.v49i2.1745
Willighagen, EgonJanocchio: Jmol and CDK based 1H coupling constant predictionposted-content10.59350/rxzh8-9yr48
Willighagen, EgonCDK is now available from your nearest Debian mirrorposted-content10.59350/g5s78-zqk90
Tsutsui, TaikiIdentification of target genes for the CDK subunits of the Mediator complex2011/12journal-article10.1111/j.1365-2443.2011.01565.x
Guidato, SoniaCyclin D2 Interacts with cdk‐5 and Modulates Cellular cdk‐5/p35 Activity1998/1journal-article10.1046/j.1471-4159.1998.70010335.x
CDK Inhibitors, Endocrine Therapy for Male Patients With Breast Cancer2019/3/8dataset10.1200/adn.19.190134
-, -Indeks Akhir Tahunjournal-article10.55175/cdk.v48i12.1588
Dutto, IlariaAssessing Cell Cycle Independent Function of the CDK Inhibitor p21CDKN1A in DNA Repair2016book-chapter10.1007/978-1-4939-2926-9_11
-, -Indeks Subjekjournal-article10.55175/cdk.v49i1.1648
Nishizawa, MasafumiMouse Cyclin-dependent Kinase (Cdk) 5 Is a Functional Homologue of a Yeast Cdk, Pho85 Kinase1999/11journal-article10.1074/jbc.274.48.33859
-, -Indeks Penulisjournal-article10.55175/cdk.v49i1.1647
CELL CYCLE-REGULATION OF THE FANCD2 PROTEIN VIA CDK-MEDIATED S592 PHOSPHORYLATIONdissertation10.23860/thesis-cantres-velez-juan-2020
Apodaca, Richard L.Source Code Documentation in Ruby: RDoc for Ruby CDKposted-content10.59350/jf1hb-6ev38
Willighagen, EgonProtein support in Bioclipse using Jmol and the CDKposted-content10.59350/23wn4-1nt07
Willighagen, EgonComparing JUnit test results between CDK trunk/ and a branchposted-content10.59350/zs3tv-pp865
Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk)component10.1021/acschembio.7b00972.s001
Figure 7. Model of how meiotic cells inhibit DNA replication during the MI–MII transition.component10.7554/elife.33309.026
Willighagen, EgonModern chemistry in the CDK: beyond the two-atom bondposted-content10.59350/h2ytc-6pt51
Willighagen, EgonOpen Source Java tool chain: CDK compiles and JUnit tests runposted-content10.59350/933ah-c7f36
Lone, WaseemSilicon-tethered colchicine aryne cyclo-adduct as a potent molecule for the abrogation of epithelial to mesenchymal transition via modulating cell cycle regulatory CDK-2 and CDK-4 kinasesposted-content10.26434/chemrxiv-2024-rs3lh
Apodaca, Richard L.From IUPAC Name to Molecular Formula with Ruby CDKposted-content10.59350/1nn38-3ef94
Zettelmeyer, FlorianCDK Digital Marketing: Addressing Channel Conflict with Data Analytics2014reference-book10.4135/9781473969650
Willighagen, EgonTrouble running the CDK JUnit tests with Cacao and Kaffeposted-content10.59350/rn78z-r7j37
Shimotohno, AkieCDKPhosphorylationother10.1002/9781119312994.apr0336
Apodaca, Richard L.MX Performance Comparison #3: Substructure Search in MX and CDKposted-content10.59350/n4y52-t3a30
Apodaca, Richard L.Agile Chemical Informatics Development with CDK and Ruby: RCDK-0.3.0posted-content10.59350/c8h7w-n4922
Futcher, A. B.General Methods for Identifying Gl-phase Substrates of Cdk Protein Kinases.1998/6/1report10.21236/ada366953
Purnamasari, Maretta RosabellaIktiosis Vulgarisjournal-article10.55175/cdk.v47i10.1085
Protein kinase (CDK/MAK)book-chapter10.1007/978-3-540-49756-1_63
Review for "ALG3 contributes to the malignant properties of OSCC cells by regulating CDK‐Cyclin pathway"2020/8/16peer-review10.1111/odi.13687/v1/review1
Review for "ALG3 contributes to the malignant properties of OSCC cells by regulating CDK‐Cyclin pathway"2020/8/17peer-review10.1111/odi.13687/v1/review2
Prasetya, DamarVarisela Neonataljournal-article10.55175/cdk.v47i12.1239
Cyclin-Dependent Kinase (CDK) Inhibitors: StructureActivity Relationships and Insights into the CDK2 Selectivity of 6Substituted 2Arylaminopurinescomponent10.1021/acs.jmedchem.6b01254.s002
Apodaca, Richard L.From SMILES to InChI: Rino, CDK, and Ruby Java Bridgeposted-content10.59350/hra9n-qry69
Pohl, M.GWK/CDK-Bank1994/1/1book-chapter10.4337/9781781954218.00152
Cyclin-Dependent Kinase (CDK) Inhibitors: StructureActivity Relationships and Insights into the CDK2 Selectivity of 6Substituted 2Arylaminopurinescomponent10.1021/acs.jmedchem.6b01254.s001
EMPIAR dataset10.6019/empiar-10438
Shimotohno, AkieCDK Phosphorylationbook-chapter10.1002/9780470988923.ch5
Ringer, LymorRole of p53 in cdk Inhibitor VMY-1-103-induced Apoptosis in Prostate Cancer2013/11/1report10.21236/ada592440
Anurogo, DitoCancer Stem Cellsjournal-article10.55175/cdk.v48i11.1549
Dutta, AnindyaAction of the p53 Effector, p2l, on its Targets: Cyclin cdk and PCNA1998/10/1report10.21236/ada368460
Apodaca, Richard L.Easily Calculate TPSA Descriptors from SMILES Strings Using Ruby CDKposted-content10.59350/8xxp3-b8077
Roovers, KristinRole of Cyclin D1 and cdk Inhibitors in Breast Cancer Pathogenesis2002/5/1report10.21236/ada407447
Apodaca, Richard L.MX Performance Comparison #2: Exhaustive Ring Perception in MX and CDKposted-content10.59350/tv70e-5c238
Rusli, RichardoRetinitis Pigmentosajournal-article10.55175/cdk.v47i7.597
Durandau, EricCross-regulation between CDK and MAPK control cellular fateposted-content10.1101/274787
Ringer, LymorRole of p53 in cdk Inhibitor VMY-1-103-Induced Apoptosis in Prostate Cancer2012/9/1report10.21236/ada567635
Kawauchi, TakeshiExtra‐cell cycle regulatory functions of cyclin‐dependent kinases (CDK) and CDK inhibitor proteins contribute to brain development and neurological disorders2013/3journal-article10.1111/gtc.12029
Yu, BoDownregulation of Cyclin D1 Alters cdk 4- and cdk 2-Specific Phosphorylation of Retinoblastoma Protein2000/6journal-article10.1006/mcbr.2000.0238
Cheng, WeiyanRecent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures2019/2journal-article10.1016/j.ejmech.2019.01.003
., SukamtoPenanganan Ketoasidosis Diabetik pada Anakjournal-article10.55175/cdk.v49i9.2039
Apodaca, Richard L.Open Benchmarks for Cheminformatics: First Performance Comparison Between CDK and MXposted-content10.59350/7nc6k-w4216
Cyclin‐Dependent Protein Kinase ( CDK )other10.1002/0471684228.egp02997
Srivastava, MansiLineage-specific CDK activity dynamics characterize early mammalian developmentposted-content10.1242/prelights.38013
Wysocki, RobertCDK Pho85 targets CDK inhibitor Sic1 to relieve yeast G1 checkpoint arrest after DNA damage2006/10journal-article10.1038/nsmb1139
Cyclin dependent kinase (CDK)2010/11journal-article10.1038/scibx.2010.1319
Cyclin-Dependent Protein Kinases (CDK)2008book-chapter10.1007/978-1-4020-6754-9_3981
Nishizawa, MasafumiPhosphorylation of Sic1, a Cyclin-dependent Kinase (Cdk) Inhibitor, by Cdk Including Pho85 Kinase Is Required for Its Prompt Degradation1998/9journal-article10.1091/mbc.9.9.2393
CDK2006book-chapter10.1007/3-540-29623-9_10003
Mahendra, CiptaPeutz-Jeghers Syndromejournal-article10.55175/cdk.v48i12.1574
Katz, MaxRichFaces CDK: Building Custom Components2011book-chapter10.1007/978-1-4302-3450-0_14
Review for "ALG3 contributes to the malignant properties of OSCC cells by regulating CDK‐Cyclin pathway"2020/10/7peer-review10.1111/odi.13687/v2/review1
Lawrenti, HastaritaHemofilia dan Perkembangan Terapinyajournal-article10.55175/cdk.v48i9.1496
Figure 4: The efficiency of tumor markers in distinguish CDK patients with normal serum creatinine from healthy controls.component10.7717/peerj.19240/fig-4
Sanchez-Diaz, AlbertoThe Mitotic Exit Network and Cdc14 phosphatase initiate cytokinesis by counteracting CDK phosphorylations and blocking polarised growth2012/8/29journal-article10.1038/emboj.2012.224
Yuliana, JeniAspek Klinis Ambliopiajournal-article10.55175/cdk.v49i1.1639
Apodaca, Richard L.Cheminformatics for the Web: Convert SD Files to HTML with Ruby CDKposted-content10.59350/gvwgq-b0x50
Turner, N.Targeting the CDK 4-6 pathway2019/3journal-article10.1016/s0960-9776(19)30078-5
Pérez-Hidalgo, LiviaCDK Inhibitors2013book-chapter10.1007/978-1-4419-9863-7_12
Apodaca, Richard L.From InChI to Image with Ruby Open Babel and Ruby CDKposted-content10.59350/r891p-vmx14
Chandra, RudiTatalaksana Melanoma Maligna Kutaneusjournal-article10.55175/cdk.v48i7.1453
Fig. 1. Ovarian enlargement and lack of blood flow in the CDK regimen with a full bladdercomponent10.17816/psaic575-154
Aprelikova, OlgaBoth p16 and p21 Families of Cyclin-dependent Kinase (CDK) Inhibitors Block the Phosphorylation of Cyclin-dependent Kinases by the CDK-activating Kinase1995/8journal-article10.1074/jbc.270.31.18195
p27 Kip1−/− Strain 32001/10/3journal-article10.1126/sageke.2001.1.tg10
Ogata, RyoheiResistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells2021/1journal-article10.1007/s12282-020-01150-8
RAYNAL, SDIFFERENTIAL-EFFECTS OF TRANSFORMING GROWTH-FACTOR-BETA-1 ON PROTEIN-LEVELS OF P21 WAF AND CDK-2 AND ON CDK-2 KINASE-ACTIVITY IN HUMAN RD AND CCL64 MINK LUNG-CELLSjournal-article10.3892/ijo.7.2.337
Teo, GloriaDiagnosis dan Tatalaksana Kegawatdaruratan Hiperkalemiajournal-article10.55175/cdk.v48i8.1447
Application of Biocatalytic Reductive Amination for the Synthesis of a Key Intermediate to a CDK 2/4/6 Inhibitorcomponent10.1021/acs.oprd.1c00255.s001
Lawrensia, SherlyDiagnosis dan Tatalaksana Artritis Tuberkulosisjournal-article10.55175/cdk.v47i8.773
Lawrensia, SherlyLung Abscess: Diagnosis and Treatmentjournal-article10.55175/cdk.v48i5.1373
EMPIAR dataset10.6019/empiar-10561
Dai, YunCDK Inhibitors in Multiple Myeloma2008book-chapter10.1007/978-1-59745-564-0_22
Nitiyoso, NugrohoAspek Imunitas pada COVID-19journal-article10.55175/cdk.v48i9.1497
., SuhartoFisioterapi Kasus Cerebral Palsy Kuadriplegia Spastikjournal-article10.55175/cdk.v49i9.2036
When a CDK Is Really a Transcription Factor2005/1/11journal-article10.1126/stke.2662005tw14
Prasetio, AdrianGangguan Psikiatri Terkait Kafeinjournal-article10.55175/cdk.v47i7.603
grant10.55776/p19894
Febriana, LydiaSuplemen untuk Terapi Obesitasjournal-article10.55175/cdk.v49i0.1964
Cyclin dependent kinase (CDK)2010/3journal-article10.1038/scibx.2010.272
Futcher, A. B.General Methods for Identifying G1-Phase Substrates of Cdk Protein Kinases.1996/6/1report10.21236/ada323678
Meijer, LaurentCDK Inhibitors2002book-chapter10.1016/b978-012476249-7/50008-4
Lone, Waseem IqbalDiscovery of Colchicine Aryne Cyclo-Adduct as a Potent Molecule for the Abrogation of Epithelial to Mesenchymal Transition Via Modulating Cell Cycle Regulatory Cdk-2 and Cdk-4 Kinasesposted-content10.2139/ssrn.4814175
Fauzi, AhmadHaglund Deformity: Diagnosis and Treatmentjournal-article10.55175/cdk.v49i10.2067
Yahya, WillyRetinopati Prematuritas : Diagnosis dan Tatalaksanajournal-article10.55175/cdk.v47i10.1080
Nitiyoso, NugrohoPilihan Pengobatan Sistemik pada Psoriasisjournal-article10.55175/cdk.v49i3.1775
Henri, P.Psoriatic epidermis is associated with upregulation of CDK 2 and inhibition of CDK 4 activity2020/3journal-article10.1111/bjd.18178
Cyclin dependent kinase (CDK)2012/4journal-article10.1038/scibx.2012.385
Dai, YunCDK Inhibitors in Leukemia and Lymphoma2019/9/17book-chapter10.1201/9780429114670-15
Karyadi, ErlindaCutaneous Mucormycosisjournal-article10.55175/cdk.v49i2.1740
Larochelle, StéphaneCDK-Activating Kinases: Detection and Activity Measurementsbook-chapter10.1385/1-59259-857-9:279
Bisbis, BadiaCyclin-dependent Kinase (CDK) Inhibitors Regulate the CDK-Cyclin Complex Activities in Endoreduplicating Cells of Developing Tomato Fruit2006/3journal-article10.1074/jbc.m506587200
Lukito, Johan IndraTinjauan atas Terapi Insulinjournal-article10.55175/cdk.v47i9.917
Karyadi, ErlindaCutaneous Mucormycosisjournal-article10.55175/cdk.v49i2.1726
Cicenas, JonasCDK Inhibitors and FDA: Approved and Orphanjournal-article10.3390/cancers16081555
Müllers, ErikCdk activity drives senescence from G2 phaseposted-content10.1101/041723
Putri, Zanty RakhmaniaBell’s Palsy: Diagnosis dan Tatalaksanajournal-article10.55175/cdk.v49i8.1986
Pricelda, AliciaTren Terapi Age-Related Macular Degenerationjournal-article10.55175/cdk.v48i12.1584
p27 Kip1−/− Strain 22001/10/3journal-article10.1126/sageke.2001.1.tg9
-, TommyAngina Prinzmetal - Diagnosis dan Tatalaksanajournal-article10.55175/cdk.v48i6.1431
Afifah Nurullah, FitriTinjauan atas N-Nitrosodimethylamine (NDMA)journal-article10.55175/cdk.v47i12.1249
Mahendro, Della SulamitaPenggunaan Antivirus untuk COVID-19journal-article10.55175/cdk.v48i7.1459
Kristiningrum, EstherPenggunaan Hydroxychloroquine dalam Tatalaksana Covid-19journal-article10.55175/cdk.v47i12.1246
Suryani, AdeliaFaktor-Faktor yang Memengaruhi Pigmentasi Manusiajournal-article10.55175/cdk.v47i11.1195
Permasutha, Made BayuTinjauan atas Kanker Rongga Mulutjournal-article10.55175/cdk.v48i3.1327
Kusumo, Inosensia DiajengTinjauan Atas Piodermajournal-article10.55175/cdk.v49i4.1822
CDK Inhibitor Triples PFS in Breast Cancer2013/1/1journal-article10.1158/2159-8290.cd-nb2012-149
ASCO TAPUR, CDK Studies Endeavor to Fill Gaps in Personalized Cancer Care Research2024/12/1dataset10.1200/acon.24.00037
Chandra, RudiPilihan Pengobatan Dermatologis Penuaan Periorbitaljournal-article10.55175/cdk.v47i12.1241
Morgan, David O.Principles of CDK regulation1995/3journal-article10.1038/374131a0
Apodaca, Richard L.CampDepict: Building a Simple SMILES Depict Web Application With JRuby, Structure CDK, and Campingposted-content10.59350/d2m6v-tag27
-, CarlsonTatalaksana Demam pada Anakjournal-article10.55175/cdk.v47i11.1200
EMPIAR dataset10.6019/empiar-10431
Decision letter: CDK-regulated dimerization of M18BP1 on a Mis18 hexamer is necessary for CENP-A loading2016/12/19peer-review10.7554/elife.23352.021
Johan, MichaelEvaluasi dan Tatalaksana Hipernatremiajournal-article10.55175/cdk.v48i6.1441
Palacios Blanco, InésCDK phospho-regulation of the Rad51-accessory factor Sfr1 and its role in meiotic recombinationdissertation10.14201/gredos.161088
Fanardy, AngelineToksin Botulinum untuk Kasus Urogenitaljournal-article10.55175/cdk.v48i3.1337
Dinari, Nur AlfiMiopia: Etiologi dan Terapijournal-article10.55175/cdk.v49i10.2069
Ciatawi, KartiniPatofisiologi Spinal Cord Injuryjournal-article10.55175/cdk.v49i5.1848
Ciatawi, KartiniPatofisiologi Spinal Cord Injuryjournal-article10.55175/cdk.v49i9.2032
Stanley, Jone A.Chromium-VI arrests cell cycle and decreases granulosa cell proliferation by down-regulating cyclin-dependent kinases (CDK) and cyclins and up-regulating CDK-inhibitors2011/7journal-article10.1016/j.reprotox.2011.05.007
Renita Sanyasi, Rosa De LimaSindrom Mona Lisajournal-article10.55175/cdk.v48i1.1258
Wijaya, SandyDiagnosis dan Tatalaksana Polisitemia Verajournal-article10.55175/cdk.v47i7.596
Lawrenti, HastaritaPenghambat Immune Checkpoint untuk Terapi Kankerjournal-article10.55175/cdk.v49i0.1966
Shamsi, ZahraConcestor kinase activation mechanism uncovers the cyclin dependence of CDK family kinasesposted-content10.1101/410902
Cherub, JaneTerapi Antikoagulan pada COVID-19journal-article10.55175/cdk.v48i6.1436
Lukito, Johan IndraGunakan Insulin dengan CERMATjournal-article10.55175/cdk.v47i10.1093
Irsyada Yusuf, AmryDiagnosis dan Tatalaksana Kriptorkhismusjournal-article10.55175/cdk.v48i3.1330
Wijaya, MeiliyanaMeningitis Kriptokokus pada Penderita HIVjournal-article10.55175/cdk.v48i1.1256
Feinberg, Bruce A.Prescribing preferences for hormone sensitive (HR+) metastatic breast cancer (mBC) in the CDK 4/6 inhibitor (CDK 4/6i) era.2020/5/20journal-article10.1200/jco.2020.38.15_suppl.e13058
Setiawan, MichaelMielopati Non Kompresif: Pendekatan Diagnosisjournal-article10.55175/cdk.v47i9.909
Dewi, Nadia PuspaAspek Klinis Dermatitis Seboroikjournal-article10.55175/cdk.v49i6.1881
Mueller, DanielAbstract 2821: Characterization of CDK inhibitors in a biochemical assay using a comprehensive panel of human CDK-cyclin complexes2016/7/15journal-article10.1158/1538-7445.am2016-2821
Besser, AlexandraCDK Inhibitors in Normal and Malignant Cells2023book-chapter10.1016/b978-0-12-821618-7.00221-2
Mahendrakrisna, DanielTatalaksana Epilepsi Refrakterjournal-article10.55175/cdk.v47i9.911
Ratna Sari, Ihda ZuyinaGambaran Sistiserkosis dan Taeniasisjournal-article10.55175/cdk.v49i3.1768
p27 Kip1−/− Strain 12001/10/3journal-article10.1126/sageke.2001.1.tg8
Carrieri, Francesca AnnaCDK 1 and CDK 2 regulate NICD 1 turnover and the periodicity of the segmentation clock2019/7journal-article10.15252/embr.201846436
Mahendra, CiptaTerapi Berbasis Sel: Perkembangan Terkinijournal-article10.55175/cdk.v49i3.1769
Clinical Trial in Healthy Volunteers and Subjects With CDKjournal-article10.31525/ct1-nct03893799
Cyclin dependent kinase (CDK); p532012/10journal-article10.1038/scibx.2012.1028
Dianky, AmandaPeran Nutrigenomik pada Tata Laksana Obesitasjournal-article10.55175/cdk.v49i0.1965
First CDK 4/6 Inhibitor Heads to Market2015/4/1journal-article10.1158/2159-8290.cd-nb2015-028
Tan, ChristineTrombosis pada Pasien COVID-19journal-article10.55175/cdk.v48i12.1571
Decision letter: CDK control pathways integrate cell size and ploidy information to control cell division2020/12/20peer-review10.7554/elife.64592.sa1
Wijaya, LupitaTatalaksana Nyeri Neuropatik Perifer dengan Sediaan Patchjournal-article10.55175/cdk.v48i9.1484
4-Arylazo-3, 5-diamino-1H-pyrazole CDK Inhibitors: SAR Study, Crystal Structure in Complex with CDK2, Selectivity, and Cellular Effectscomponent10.1021/jm0605740.s001
CRESCENZI, ELVIRAAssociation of Bcl‐2 with Cyclin A/Cdk‐2 Complex and Its Effects on Cdk‐2 Activity2002/11journal-article10.1111/j.1749-6632.2002.tb04647.x
Decker, TCell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p272002/3/1journal-article10.1038/sj.leu.2402389
Mostafa, Heba H.Herpes Simplex Virus 1 Upregulates p35, Alters CDK-5 Localization, and Stimulates CDK-5 Kinase Activity during Acute Infection in Neurons2015/5journal-article10.1128/jvi.00106-15
Sondhi, Sham M.Synthesis, anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some Schiff’s bases2006/6journal-article10.1016/j.bmc.2006.01.054
Chandra, RudiAspek Dermatologi Penuaan Kulit Periorbitaljournal-article10.55175/cdk.v47i9.920
-, CecileDiagnosis dan Tatalaksana Paroxysmal Nocturnal Hemoglobinuriajournal-article10.55175/cdk.v48i7.1452
Falco, Giulia DeCdk Inhibitors: Background and Introductionbook-chapter10.1385/1-59259-401-8:01
Supit, BrigitaInfeksi TORCH Maternal dan Kongenitaljournal-article10.55175/cdk.v48i9.1499
Wisesaputra, Tjok Agung PurnamaBest Vitelliform Dystrophyjournal-article10.55175/cdk.v47i7.599
-, FilbertoDiagnosis dan Tatalaksana Congenital Talipes Equino Varus (CTEV)journal-article10.55175/cdk.v48i1.1270
Kumala, MarciaSuplementasi Vitamin B1 untuk Pasien Sepsisjournal-article10.55175/cdk.v47i8.783
Bird, R.CurtisThe Cyclin/Cyclin-Dependent Kinase (cdk) Complex1997book-chapter10.1016/b978-012100160-5/50006-3
A novel and robust molecular switch actuating the quantitative model of eukaryotic Cdk controlproceedings-article10.18699/sbb-2022-104
Patterson, James O.Synergistic CDK control pathways maintain cell size homeostasisposted-content10.1101/2020.11.25.397943